Republicans weigh Marshall for FDA as Overton wobbles
Key Points:
- Republicans are considering Sen. Roger Marshall as an alternative nominee to lead the FDA due to Heidi Overton's confirmation struggles, facing opposition from anti-abortion activists and moderate Republicans.
- Marshall, a Kansas Republican and doctor who recently lost his reelection bid, is viewed as a stronger and more confirmable candidate, with the Senate health committee set to vote on Overton’s nomination soon.
- The White House has not made a final decision on replacing Overton, but there is growing internal acknowledgment that her confirmation path is difficult, and a senator nominee like Marshall could be more easily confirmed.
- The FDA has been under acting leadership since May, with Kyle Diamantas serving as acting commissioner, but he may depart the agency regardless of Overton’s nomination outcome.
- Republicans face a tight timeline with only about six weeks left in their Senate majority to confirm President Trump’s nominees, adding pressure to resolve the FDA leadership issue quickly.